Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02827318
Other study ID # DisGL
Secondary ID
Status Completed
Phase N/A
First received June 29, 2016
Last updated July 5, 2016
Start date September 2015
Est. completion date December 2015

Study information

Verified date July 2016
Source Swansea University
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

Reducing the glycaemic load (GL) of the diet may benefit appetite control but its utility is complicated by psychological influences on eating. Disinhibited behaviour, a risk factor for overconsumption, is characterized by reduced prefrontal cortex activity, which in turn directly modulates vagal tone; a phenomenon inversely associated with blood glucose (BG) and insulin levels. This double blind randomised controlled trial explores the influence of disinhibited eating and vagal tone (heart rate variability) on the postprandial response to GL and hunger.


Description:

There is growing recognition that lowering the glycaemic load of the diet might reduce a range of cardiovascular risk factors such as raised plasma triglycerides, HbA1c and C reactive protein and aid in body weight regulation. A proposed mechanism includes higher satiety and prolonged satiation by virtue of improved postprandial metabolic control, although, whether lower GL meals result in greater weight loss or increased satiety is still a matter of debate. One matter complicating the issue is that the desire to consume food may be driven by psychological factors; food reward centres in the brain may override hormonal regulation of food intake. Amongst psychological factors disinhibition has the largest and most consistent body of empirical data that associates it with weight gain although the mechanisms involved are unknown. This study will investigate whether, irrespective of BMI or habitual diet, disinhibited eaters have greater glycaemic excursions following a high glycaemic load drink and whether this predicts subsequent satiation.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- Young healthy adults who scored either high or low on the Three factor eating questionnaire disinhibition subscale

Exclusion Criteria:

Participants were excluded if they

- had a cardiovascular or metabolic disorder

- gastrointestinal problems

- were pregnant

- had a current diagnosis of a mood or eating disorder

- and/or were taking medications or herbal supplements to manage body weight or control appetite

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Isomaltulose
75g Isomaltulose (low glycaemic load intervention)
Glucose
75g Glucose (high glycaemic load intervention)
Sweetened water
Sweetened water will be used as a control

Locations

Country Name City State
United Kingdom Swansea University Swansea West Glamorgan

Sponsors (1)

Lead Sponsor Collaborator
Swansea University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in blood glucose Blood glucose was monitored from finger pricks using an ExacTech sensor (Medisense Britain Limited) that using an enzymic method, coupled with microelectronic measurement. Change in blood glucose from baseline to after 30 minutes will assess the speed of incline. From baseline to 30 minutes Yes
Primary Change in blood glucose As above to assess the speed of decline. from 30 to 150minutes Yes
Secondary Hunger Participants were asked to respond to the question "how hungry are you feeling right now" on a single 100mm visual analogue scale anchored by "Not at all" and "Extremely". 30, 150 minutes No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06061419 - The Effect of Huel Powder on Appetite N/A
Completed NCT03850990 - Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss N/A
Recruiting NCT03978975 - Water Exercise and Health (WATHEALTH) N/A
Active, not recruiting NCT06082778 - ZOE's Ferment Experiment N/A
Completed NCT05734209 - How Does Eating Behavior and Hunger in Virtual Reality Meals Compare to Real Meals? N/A
Completed NCT02948816 - The Effects of Social Media on Food Intake and Behaviour N/A
Completed NCT03900130 - The Omnibus Satiety Metric: Predicting Satiety in Humans Through Brain, Blood, and Subjective Data N/A
Recruiting NCT05196763 - Maximizing Nutrition Education to Meet Dietary and Food Security of Children and Parents N/A
Completed NCT03489226 - Capsimax Effect on Metabolic Rate, Satiety and Food Intake N/A
Completed NCT03656146 - Food for Thought: Food Insecurity Screening in the Emergency Department N/A
Recruiting NCT06340087 - Impact Hesperetin in Combination With Sucrose on Blood Glucose Regulation Early Phase 1
Completed NCT01809925 - Study of Psyllium 6.8 g Versus Placebo on Satiety in Healthy Volunteers N/A
Completed NCT01562678 - Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI Phase 4
Completed NCT04884373 - Patient Satiety as an Indicator of Stomach Contents and Fluid Volume
Completed NCT02505490 - The Effect of Television Watching on Liking of Food N/A
Completed NCT02577705 - Building Wealth and Health Network: A Microfinance/TANF Demonstration Project N/A
Recruiting NCT03537781 - The Effect of Food Labelling and Satiety on Individuals Food Choice N/A
Completed NCT02477410 - Effects of Hydrolysed Porcine Proteins on Muscle Protein Synthesis and Appetite N/A
Completed NCT01924130 - School Breakfast Policy Initiative Study N/A
Completed NCT01413217 - Which is a Better Breakfast? Egg or Cereal?